Clinical Trial Update: Predictors of Long-Term Evolution in Long COVID; 4-Year Follow-Up. (BioICOPER Follow-up Study)

View source ↗

Summary

Ongoing observational study (BioICOPER Follow-up) seeking predictors of long-term evolution in long COVID, with a four-year follow-up and active recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Long Covid
• Post-acute Sequelae of Sars-cov-2 Infection

Snippet

Sponsor: Instituto de Investigación Biomédica de Salamanca | Conditions: Persistent COVID Condition | Status: RECRUITING